Stockreport

Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor

Senseonics Holdings, Inc.  (SENS) 
Last senseonics holdings, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: senseonics.com/investor-relations
PDF Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older [Read more]